2-acetyl-4(5)-tetrahydroxybutylimidazole has been researched along with concanavalin a in 1 studies
| Studies (2-acetyl-4(5)-tetrahydroxybutylimidazole) | Trials (2-acetyl-4(5)-tetrahydroxybutylimidazole) | Recent Studies (post-2010) (2-acetyl-4(5)-tetrahydroxybutylimidazole) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 43 | 0 | 11 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradbury, MG; Doherty, KV; Lyons, AB; Parish, CR | 1 |
1 other study(ies) available for 2-acetyl-4(5)-tetrahydroxybutylimidazole and concanavalin a
| Article | Year |
|---|---|
The immunosuppressive compound 2-acetyl-4-tetrahydroxybutyl imidazole inhibits the allogeneic mixed lymphocyte reaction by sequestration of a recirculating subpopulation of T cells.
Topics: Animals; B-Lymphocytes; Cell Division; Cell Movement; Concanavalin A; Female; Imidazoles; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocyte Subsets | 1996 |